Markets

Insider Trading

Hedge Funds

Retirement

Opinion

8 Best Pet Stocks to Buy According to Billionaires

The pet industry is expected to continue growing in the coming years, driven by changing consumer preferences and innovative trends. This growth is supported by increasing pet ownership, particularly among millennials, who see pets as family members and are ready to invest in premium pet care. According to the 2024 APPA National Pet Owners Survey, 82 million US households own a pet. This shows how common pet ownership is becoming across the country. Millennials make up 32% of all pet owners.

READ ALSO: 12 Best Health Insurance Stocks to Buy in 2025 and 8 Fastest Growing AI Stocks To Buy Right Now.

The rise of premium supplements is another key factor expected to drive growth. This aligns with the trend of the “humanization of pets,” where pet parents seek nutritious and healthy solutions for their animals. As a result, there is a growing demand for sustainable and organic pet products.

These trends highlight a deep emotional connection between pets and pet parents, which is driving innovation and spending in the industry.

According to the American Pet Products Association (APPA), US pet industry sales are projected to reach $150.6 billion in 2024. Pet food is expected to remain the largest segment, with spending rising to $66.9 billion. Other major segments include Supplies, Live Animals, and Over-the-counter (OTC) Medicine at $32 billion, as well as Veterinary Care and Product Sales projected to reach $39.1 billion. These segments offer significant opportunities for companies involved in pet care products and services.

With this background in mind, let’s take a look at the 8 best pet stocks to buy according to billionaires.

Pixabay/Public domain

Our Methodology

To compile our list of the 8 best pet stocks to buy according to billionaires, we looked for the largest pet companies. We reviewed our own rankings, financial media reports, ETFs, and various online resources to compile a list of the best pet stocks. Next, we focused on the top 8 pet stocks most favored by billionaires. Data for the number of billionaire investors for each stock was taken from Insider Monkey’s Q4 2024 database. Finally, the 8 best pet stocks to buy were ranked in ascending order based on the number of billionaires holding stakes in them as of Q4 2024.

Additionally, we mentioned the hedge fund sentiment surrounding each stock, which was taken from Insider Monkey’s Q4 2024 database of more than 1,000 elite hedge funds.

Why do we care about what hedge funds do? The reason is simple: our research has shown that we can outperform the market by imitating the top stock picks of the best hedge funds. Our quarterly newsletter’s strategy selects 14 small-cap and large-cap stocks every quarter and has returned 373.4% since May 2014, beating its benchmark by 218 percentage points (see more details here).

8 Best Pet Stocks to Buy According to Billionaires

8. The J. M. Smucker Company (NYSE:SJM)

Number of Billionaire Investors: 10

Number of Hedge Fund Holders: 37

The J. M. Smucker Company (NYSE:SJM), or simply Smuckers, is an American company that manufactures and markets coffee, peanut butter, fruit spreads, frozen handheld, sweet baked goods, dog snacks, and cat food. The company offers a diverse portfolio of brands available across North America, including Folgers, Dunkin’, Café Bustelo, Jif, Uncrustables, Smucker’s, Hostess, Milk-Bone, and Meow Mix. According to billionaires, The J. M. Smucker Company (NYSE:SJM) is one of the best pet stocks to buy.

The company is focused on portfolio optimization and prioritization of resources. On March 3, The J. M. Smucker Company (NYSE:SJM) completed the divestiture of its Cloverhill and Big Texas brands, as well as certain private label products, to JTM Foods for approximately $40 million. This transaction, which also includes a manufacturing facility in Chicago, is part of the company’s strategy to focus resources on its most important brands.

On March 24, Morgan Stanley analyst Megan Alexander Clapp initiated coverage of The J. M. Smucker Company (NYSE:SJM), giving it an “Overweight” rating and a price target of $123. The analysts are confident in the company’s growth prospects. The firm’s evaluation suggests that The J. M. Smucker Company’s (NYSE:SJM) portfolio of brands is expected to outperform competitors, particularly in center-of-store categories. Morgan Stanley believes that The J. M. Smucker Company’s (NYSE:SJM) current valuation does not fully account for the sustained success of the Uncrustables product line, the coffee segment’s resilience to inflationary pressures, and early signs of stabilization in the Hostess brand.

7. Elanco Animal Health Incorporated (NYSE:ELAN)

Number of Billionaire Investors: 10

Number of Hedge Fund Holders: 37

Elanco Animal Health Incorporated (NYSE:ELAN) ranks among the best pet stocks to invest in. As a leading animal health company, it produces medicines and vaccinations to treat and prevent diseases in farm animals and pets. Elanco Animal Health Incorporated (NYSE:ELAN) has about 200 brands and its products are sold in more than 90 countries.

The company is currently focused on innovation and expansion. It aims to deliver blockbuster products that meet the critical needs of pets and their owners in the markets it serves. In January, Elanco Animal Health Incorporated (NYSE:ELAN) launched Credelio Quattro, the first and only monthly chewable tablet for dogs that provides protection against ticks, fleas, heartworm disease, roundworms, hookworms, and tapeworms. Additionally, the company reported that Zenrelia, a once-daily treatment for dogs to treat itchy and irritated skin caused by allergic and atopic dermatitis, has been adopted in over 8,000 US clinics. This represents a penetration of nearly 30%. Zenrelia was also launched in Japan in November 2024 and in Canada in January 2025 as part of Elanco Animal Health Incorporated’s (NYSE:ELAN) global expansion efforts.

6. Tractor Supply Company (NASDAQ:TSCO)

Number of Billionaire Investors: 10

Number of Hedge Fund Holders: 40

Tractor Supply Company (NASDAQ:TSCO) is an American company that sells home improvement, agriculture, lawn and garden maintenance, livestock, and pet care products and supplies. The company serves recreational farmers, ranchers, homeowners, gardeners, and pet enthusiasts with more than 2,200 stores in 49 states. Tractor Supply Company (NASDAQ:TSCO) also has more than 200 Petsense by Tractor Supply stores in 23 states. Petsense is a small-box pet specialty supply retailer providing products and services for pet owners. TSCO ranks among the best pet stocks to invest in according to billionaires.

The company is strategically expanding its pet care offerings through acquisitions and new product launches. In December 2024, Tractor Supply Company (NASDAQ:TSCO) completed its acquisition of Allivet, a leading online pet and animal pharmacy that is licensed in all 50 states with 3 distribution centers that allow it to reach a large majority of the US with next day delivery. This transaction helps Tractor Supply Company (NASDAQ:TSCO) reach more customers and grow its total addressable market by $15 billion to $225 billion. Additionally, in January 2025, the company launched 4health Shreds, a new dog food product that combines crunchy kibble and protein-rich shreds for better texture and nutrition. 4health Shreds products are priced under $55 for a 35-pound bag to offer over 20% better value than comparable national brands.

5. Spectrum Brands Holdings, Inc. (NYSE:SPB)

Number of Billionaire Investors: 11

Number of Hedge Fund Holders: 38

Spectrum Brands Holdings, Inc. (NYSE:SPB) is an American global consumer products company that offers a portfolio of leading brands across pet care, home and garden, and personal care. The company is a major supplier of pet products for dogs, cats, birds, fish, and small animals. The company’s products are sold by the world’s top retailers and are available in more than 100 countries. Spectrum Brands Holdings, Inc. (NYSE:SPB) ranks among the best pet stocks to invest in.

Over the past year, the company has prioritized investments in brand-focused initiatives to drive top-line growth. This included upgrading capabilities in commercial operations, innovation, marketing, and advertising. In Q1 of Fiscal 2025, which ended December 29, 2024, Spectrum Brands Holdings, Inc. (NYSE:SPB) increased brand-focused investments by over $8 million compared to the same period last year. The company is also focused on e-commerce expansion and continues to strategically invest in inventory to support sales growth and e-commerce leadership capabilities. In its Global Pet Care segment, Spectrum Brands Holdings, Inc. (NYSE:SPB) is expanding its Good ‘N’ Fun brand with Good ‘N’ Tasty for cat treats and toppers. The company is also planning a complete nutrition dog food line in North America under the Good Boy brand later this year.

4. Freshpet, Inc. (NASDAQ:FRPT)

Number of Billionaire Investors: 11

Number of Hedge Fund Holders: 40

Freshpet, Inc. (NASDAQ:FRPT) is an American pet food company. Its cat food and dog food products are prepared by veterinary nutritionists and marketed as nutritious and fresh. The company’s food products are available in select grocery, mass, club, pet specialty, natural, and digital retailers across the US, Canada, and Europe. Freshpet, Inc. (NASDAQ:FRPT) ranks among the best pet stocks to invest in.

On February 24, Jefferies upgraded Freshpet, Inc. (NASDAQ:FRPT) from a “Hold” to a “Buy” rating while reducing the stock’s price target to $150 from $155. This adjustment followed the company’s strong Q4 2024 results. The analysts noted the persistent strength of the pet premiumization trend and improvements in the broader pet industry. Jefferies analysts forecast Freshpet, Inc.’s (NASDAQ:FRPT) sales to grow at a compound annual growth rate of 23% through 2027, alongside expanding profit margins, which the analysts see as a rare combination. The positive outlook is supported by promising trends in the pet industry. Jefferies believes these factors position Freshpet, Inc. (NASDAQ:FRPT) for continued growth and profitability over the next few years.

3. Chewy, Inc. (NYSE:CHWY)

Number of Billionaire Investors: 11

Number of Hedge Fund Holders: 48

Chewy, Inc. (NYSE:CHWY) is an American pet company that operates as an online retailer of pet food and treats, pet supplies, pet care, and other pet-related products. The company serves the contiguous United States and has expanded to Southern Ontario in Canada as well. Chewy, Inc. (NYSE:CHWY) ranks among the best pet stocks to buy.

On March 20, TD Cowen analyst William Kerr reiterated a “Buy” rating for Chewy, Inc. (NYSE:CHWY) with a price target of $45. The firm’s analyst highlighted the company’s strong financial outlook ahead of its Q4 2024 earnings. Kerr expects Chewy, Inc. (NYSE:CHWY) to report Q4 2024 revenues of approximately $3.2 billion, which would represent a 13% year-over-year growth. This growth is expected to be driven by strong Autoship sales. Through the Autoship subscription program, Chewy, Inc. (NYSE:CHWY) allows customers to set up automatic recurring orders for their preferred pet supplies, which ensures recurring sales. Kerr also predicts an improvement in gross margin to 29.3%, up from 28.2% in the fourth quarter of the previous year, supported by advertising growth. These figures align with market expectations and the higher end of the company’s guidance.

2. IDEXX Laboratories, Inc. (NASDAQ:IDXX)

Number of Billionaire Investors: 14

Number of Hedge Fund Holders: 58

IDEXX Laboratories, Inc. (NASDAQ:IDXX) is an American multinational corporation that offers diagnostic and software products to the pet health, livestock, poultry, water testing, and dairy markets. The company’s solutions and products are sold in over 175 countries and territories. IDEXX Laboratories, Inc. (NASDAQ:IDXX) ranks among the best pet stocks to invest in.

The company is actively introducing new technologies and solutions that address bottlenecks in veterinary practices and meet the demands of its customers. In the fourth quarter of 2024, IDEXX Laboratories, Inc. (NASDAQ:IDXX) launched the IDEXX inVue Dx Cellular Analyzer, a slide-free tool that detects the most common cytologic changes found in ear and blood samples. It uses deep AI learning models to provide practitioners with reference-laboratory quality results in 10 minutes. Additionally, IDEXX Laboratories, Inc. (NASDAQ:IDXX) plans to release the IDEXX Cancer Dx screening for canine lymphoma in the US and Canada by late March 2025.

1. Zoetis Inc. (NYSE:ZTS)

Number of Billionaire Investors: 15

Number of Hedge Fund Holders: 76

Zoetis Inc. (NYSE:ZTS) is an American animal health company. It is one of the world’s largest producers of medicine and vaccinations for pets and livestock. The company’s medicines, vaccines, diagnostics, and technologies are sold in over 100 countries. Zoetis Inc. (NYSE:ZTS) ranks among the best pet stocks to buy according to billionaires.

The company is strategically focused on driving innovation and expanding its product portfolio. After its Q3 2024 quarterly earnings announcement, Zoetis Inc. (NYSE:ZTS) achieved approvals for key products in new markets. Revolution Plus, which treats ticks, fleas, ear mites, lice, and gastrointestinal worms and prevents heartworm disease in cats, was approved in Brazil. Revolution Plus also received approval in the US and Canada for an additional claim for preventing flea tapeworm infections. Librela, the first injectable monoclonal antibody for osteoarthritis pain in dogs, received approvals in El Salvador and South Korea. Additionally, Simparica and Simparica Trio were approved in the US for treating and controlling Asian longhorned tick infestations in dogs. Zoetis Inc. (NYSE:ZTS) is successfully addressing unmet needs in animal health while expanding globally. This positions the company as a leader in animal healthcare.

READ NEXT: 20 Best AI Stocks To Buy Now and 30 Best Stocks to Buy Now According to Billionaires.

Disclosure: None. Insider Monkey focuses on uncovering the best investment ideas of hedge funds and insiders. Please subscribe to our free daily e-newsletter to get the latest investment ideas from hedge funds’ investor letters by entering your email address below.

The $250 Trillion AI Hype is Real. A few years from now, you’ll probably wish you’d bought this stock.

Dr. Inan Dogan

Dr. Ian Dogan

Co-Founder and Research Director at Insider Monkey

When Jeff Bezos said that one breakthrough technology would shape Amazon’s destiny, even Wall Street’s biggest analysts were caught off guard.

Fast forward a year and Amazon’s new CEO Andy Jassy described generative AI as a “once-in-a-lifetime” technology that is already being used across Amazon to reinvent customer experiences.

At the 8th Future Investment Initiative conference, Elon Musk predicted that by 2040 there would be at least 10 billion humanoid robots, with each priced between $20,000 and $25,000.

Do the math. According to Musk, this technology could be worth $250 trillion by 2040.

Put another way, that’s roughly equal to:

  • 175 Teslas
  • 107 Amazons
  • 140 Metas
  • 84 Googles
  • 65 Microsofts
  • And 55 Nvidias

And here’s the wild part — this $250 trillion wave isn’t tied to one company, but to an entire ecosystem of AI innovators set to reshape the global economy.

It’s a leap so massive, it could reshape how businesses, governments, and consumers operate worldwide.

Even if that $250 trillion figure sounds ambitious, major firms like PwC and McKinsey still see AI unlocking multi-trillion-dollar potential.

How could anything be worth that much?

The answer lies in a breakthrough so powerful it’s redefining how humanity works, learns, and creates.

And this breakthrough has already set off a frenzy among hedge funds and Wall Street’s top investors.

What most investors don’t realize is that one under-owned company holds the key to this $250 trillion revolution.

In fact, Verge argues this company’s supercheap AI technology should concern rivals.

Before I reveal the details, let’s talk about how some of the richest people on the planet are positioning themselves.

  • Bill Gates sees artificial intelligence as the “biggest technological advance in my lifetime,” more transformative than the internet or personal computer, capable of improving healthcare, education, and addressing climate change.
  • Larry Ellison — through Oracle, is spending billions on Nvidia chips and partnering with Cohere to embed generative AI across Oracle’s cloud and apps.
  • Warren Buffett — not known for tech hype — says this breakthrough could have a ‘hugely beneficial social impact.

When billionaires from Silicon Valley to Wall Street line up behind the same idea — you know it’s worth paying attention to.

Even as we admire what Tesla, Nvidia, Alphabet, and Microsoft have built, we believe an even greater opportunity lies elsewhere…

But the real story isn’t Nvidia — it’s a much smaller company quietly improving the critical technology that makes this entire revolution possible.

And judging by what I’m hearing from both Silicon Valley insiders and Wall Street veterans…

This prediction might not be bold at all:

A few years from now, you’ll wish you’d owned this stock.

The best part? You can discover everything about this company and its groundbreaking technology right now.

I’ve compiled everything you need to know about this groundbreaking company in a detailed, members-only report.

Trust me — you’ll want to read this report before putting another dollar into any tech stock.

For a ridiculously low price of just $9.99 a month, you can unlock a year’s worth of in-depth investment research and exclusive insights – that’s less than a single fast food meal!

Here’s what to do next:

1. Subscribe to our Premium Readership Newsletter for just $9.99 a month. (33% Off – was $14.99).

2. Enjoy a year of ad-free browsing, exclusive access to our in-depth report on the revolutionary AI company, and the upcoming issues of our Premium Readership Newsletter over the next 12 months.

3. Sit back, relax, and know that you’re backed by our ironclad 30-day money-back guarantee.

Don’t miss out on this incredible opportunity! Subscribe now and take control of your AI investment future!

<b>Cancel anytime.</b> Turn off auto-renewal via our website with just a click.

 

Buy This $3 Stock Now Before the 400% Surge Begins

Dr. Inan Dogan

Dr. Ian Dogan

Co-Founder and Research Director at Insider Monkey

My name is Inan Dogan. I’m the co-founder and Research Director of Insider Monkey. I have an important message for you today.

Since March 2017, my stock picks have returned 16.5% annually. Today, I’ve found an opportunity even bigger than my British American Tobacco call.

Two years ago, Wall Street wrote off British American Tobacco (BTI) as a “melting ice cube.” The stock had crashed 40% from its peak, and consensus said the business was dying.

We looked under the cover and realized they were wrong.

We alerted our subscribers, and BTI returned 90% in just 16 months.

Now if you had invested just $10,000 in BTI in June 2024, you’d be sitting on $19,000 in October 2025.

Today, we have identified a nearly identical pattern in a digital-first giant trading at $3.

While the market panics over a surface-level revenue decline, our PhD-led research shows management has actually surgically cut $100 million in waste to focus on high-margin growth.

This pattern is a hallmark of our 16.5% annual return track record. The current opportunity offers a 400% upside potential—dwarfing even our 90% BTI return.

Get the ticker for our new “Underdog” pick and the full BTI case study for just 99 cents.

This exclusive offer is for NEW newsletter subscribers ONLY! Join our Premium Readership Newsletter for only $0.99 and become part of a savvy investor community.!

This offer vanishes in 7 days, so don’t miss your chance to lock in market beating returnsSign up NOW! The monthly newsletter comes with a 30-day, no-risk money-back guarantee. This offer is available to the first 1000 new investors who respond.

Regular price $9.99/mo. Cancel anytime.

Space is Limited! Only 1000 spots are available for this exclusive offer. Don’t let this chance slip away – subscribe to our Premium Readership Newsletter today and unlock the potential for a life-changing investment.

Here’s what to do next:

1. Head over to our website and subscribe to our Premium Readership Newsletter for just $0.99.

2. Enjoy a month of ad-free browsing, exclusive access to our in-depth report on the Trump tariff and nuclear energy company as well as the revolutionary AI-robotics company, and the upcoming issues of our Premium Readership Newsletter.

3. Sit back, relax, and know that you’re backed by our ironclad 30-day money-back guarantee.

Don’t miss out on this incredible opportunity! Subscribe now and take control of your AI investment future!

Regular price $9.99/mo. Cancel anytime.